MWTX-05

N/A

Report date: 2026/05/08 20:02:52
First In Class

Base Information

Drug NameMWTX-05
Drug Alias NameMWTX-05MWTX05
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMyasthenic Syndromes, Congenital
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMabwell Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMabwell Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMyasthenic Syndromes, Congenital
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A